GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » EPS (Basic)

Zahravi Pharmacutical Co (XTEH:DZAH1) EPS (Basic) : IRR (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co EPS (Basic)?

Zahravi Pharmacutical Co's basic earnings per share (Basic EPS) for the six months ended in . 20 was IRR0.00. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Zahravi Pharmacutical Co's EPS (Diluted) for the six months ended in . 20 was IRR0.00. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Zahravi Pharmacutical Co's EPS without NRI for the six months ended in . 20 was IRR0.00. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Zahravi Pharmacutical Co EPS (Basic) Historical Data

The historical data trend for Zahravi Pharmacutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co EPS (Basic) Chart

Zahravi Pharmacutical Co Annual Data
Trend
EPS (Basic)

Zahravi Pharmacutical Co Semi-Annual Data
EPS (Basic)

Zahravi Pharmacutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zahravi Pharmacutical Co's Basic EPS for the fiscal year that ended in . 20 is calculated as


Zahravi Pharmacutical Co's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co  (XTEH:DZAH1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zahravi Pharmacutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zahravi Pharmacutical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co Headlines

No Headlines